Anaplastic Oligodendroglioma (AO) Completed Phase 1 Trials for Measles virus vaccine live attenuated (DB10315)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00390299
Viral Therapy in Treating Patients With Recurrent Glioblastoma MultiformeTreatment